• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 K 状态与腹膜透析患者死亡率和心血管事件的关系。

Associations of vitamin K status with mortality and cardiovascular events in peritoneal dialysis patients.

机构信息

Department of Nephrology, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Guangdong, People's Republic of China.

Department of Nephrology, Central Municipal Hospital of Huizhou, Guangdong, People's Republic of China.

出版信息

Int Urol Nephrol. 2019 Mar;51(3):527-534. doi: 10.1007/s11255-019-02080-x. Epub 2019 Jan 28.

DOI:10.1007/s11255-019-02080-x
PMID:30689181
Abstract

PURPOSE

Vitamin K deficiency, expressed by a high level of desphospho-uncarboxylated matrix GLA protein (dp-ucMGP), is highly prevalent in dialysis patients. However, the predictive ability of the vitamin K status remains unclear in continuous ambulatory peritoneal dialysis (CAPD) patients.

METHODS

158 prevalent CAPD patients with a median level of dp-ucMGP of 1093 (752, 1485) pmol/L were enrolled. Patient outcomes including all-cause mortality and cardiovascular events (CVEs) were recorded during follow-up. Survival curves were performed using Kaplan-Meier method, and the influences of dp-ucMGP on outcomes were analyzed by Cox regression models.

RESULTS

A total of 59 deaths and 82 new episodes of CVEs occurred during median follow-up of 31.4 ± 13.1 months (range: 3.8-48.0 months). Kaplan-Meier analysis revealed patients with higher dp-ucMGP levels (≥ 1093 pmol/L) had an increased risk for both mortality (P = 0.005) and CVEs (P < 0.001). Multivariable Cox regression confirmed that higher dp-ucMGP levels increase the mortality risk [hazard ratio (HR), 1.763; 95% CI 1.045-3.291] and CVEs (HR, 1.846; 95% CI 1.074-3.172). For every 100 pmol/L increase in serum dp-ucMGP, the adjusted HRs for mortality and CVEs were 1.054 (95% CI 1.008-1.106) and 1.034 (95% CI 1.012-1.089), respectively.

CONCLUSIONS

Vitamin K deficiency, as expressed by high dp-ucMGP levels, showed independently associations with mortality and CVEs in CAPD patients.

摘要

目的

维生素 K 缺乏症表现为无羧基化基质 GLA 蛋白(dp-ucMGP)水平升高,在透析患者中非常普遍。然而,其在持续性非卧床腹膜透析(CAPD)患者中的预测能力尚不清楚。

方法

纳入了 158 例中位 dp-ucMGP 水平为 1093(752,1485)pmol/L 的 CAPD 患者。在随访期间记录了患者的结局,包括全因死亡率和心血管事件(CVE)。使用 Kaplan-Meier 法绘制生存曲线,Cox 回归模型分析 dp-ucMGP 对结局的影响。

结果

中位随访 31.4±13.1 个月(范围:3.8-48.0 个月)期间,共有 59 例死亡和 82 例新发 CVE。Kaplan-Meier 分析显示,dp-ucMGP 水平较高(≥1093 pmol/L)的患者死亡(P=0.005)和 CVE(P<0.001)的风险均增加。多变量 Cox 回归证实,较高的 dp-ucMGP 水平增加了死亡率风险[危险比(HR),1.763;95%可信区间(CI)1.045-3.291]和 CVE(HR,1.846;95% CI 1.074-3.172)。血清 dp-ucMGP 每增加 100 pmol/L,死亡率和 CVE 的校正 HR 分别为 1.054(95% CI 1.008-1.106)和 1.034(95% CI 1.012-1.089)。

结论

维生素 K 缺乏症,表现为 dp-ucMGP 水平升高,与 CAPD 患者的死亡率和 CVE 独立相关。

相似文献

1
Associations of vitamin K status with mortality and cardiovascular events in peritoneal dialysis patients.维生素 K 状态与腹膜透析患者死亡率和心血管事件的关系。
Int Urol Nephrol. 2019 Mar;51(3):527-534. doi: 10.1007/s11255-019-02080-x. Epub 2019 Jan 28.
2
Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease.去羧基化骨钙素与慢性稳定型血管病患者的死亡风险相关。
Atherosclerosis. 2014 Jul;235(1):162-8. doi: 10.1016/j.atherosclerosis.2014.04.027. Epub 2014 May 6.
3
Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population.无活性基质 Gla 蛋白与不良健康结局有因果关系:佛兰芒人群中的孟德尔随机化研究。
Hypertension. 2015 Feb;65(2):463-70. doi: 10.1161/HYPERTENSIONAHA.114.04494. Epub 2014 Nov 24.
4
Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.循环中未羧化基质Gla蛋白,一种维生素K状态的标志物,作为心血管疾病的危险因素。
Maturitas. 2014 Feb;77(2):137-41. doi: 10.1016/j.maturitas.2013.10.008. Epub 2013 Oct 24.
5
Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.非羧化基质 Gla 蛋白:维生素 K 状态和心血管风险的生物标志物。
Clin Biochem. 2020 Sep;83:49-56. doi: 10.1016/j.clinbiochem.2020.05.005. Epub 2020 May 15.
6
Vitamin K status and mortality after kidney transplantation: a cohort study.维生素 K 状态与肾移植后死亡率:队列研究。
Am J Kidney Dis. 2015 Mar;65(3):474-83. doi: 10.1053/j.ajkd.2014.09.014. Epub 2014 Nov 12.
7
Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.循环非磷酸化羧化基质Gla蛋白可预测终末期肾病患者的生存率。
J Am Soc Nephrol. 2011 Feb;22(2):387-95. doi: 10.1681/ASN.2010040339.
8
The role of kidney transplantation and phosphate binder use in vitamin K status.肾移植和磷结合剂的应用对维生素 K 状态的影响。
PLoS One. 2018 Aug 30;13(8):e0203157. doi: 10.1371/journal.pone.0203157. eCollection 2018.
9
Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.肾移植受者的维生素 K 摄入量与血浆去羧基化未羧化基质 Gla 蛋白水平。
PLoS One. 2012;7(10):e47991. doi: 10.1371/journal.pone.0047991. Epub 2012 Oct 31.
10
Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.去羧基化骨钙素在心血管风险患者术后增加。
Nutrients. 2018 Jan 5;10(1):46. doi: 10.3390/nu10010046.

引用本文的文献

1
Inactive Matrix Gla Protein and Cardiovascular Outcomes: The Multi-Ethnic Study of Atherosclerosis.无活性基质Gla蛋白与心血管结局:动脉粥样硬化多民族研究
J Am Heart Assoc. 2025 Mar 4;14(5):e036459. doi: 10.1161/JAHA.124.036459. Epub 2025 Feb 19.
2
Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn.维生素 K 治疗肾病患者血管钙化:方兴未艾,仍待探索。
Nutrients. 2024 Jun 7;16(12):1798. doi: 10.3390/nu16121798.
3
Development of standardized nursing terminology for the process documentation of patients with chronic kidney disease.

本文引用的文献

1
Vitamin K and bone.维生素K与骨骼
Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):200-206. doi: 10.11138/ccmbm/2017.14.1.200. Epub 2017 Oct 25.
2
Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up.慢性肾脏病中的维生素K缺乏:证据正在积累。
Am J Nephrol. 2017;45(1):1-3. doi: 10.1159/000451070. Epub 2016 Nov 15.
3
Cardiovascular complications in chronic dialysis patients.慢性透析患者的心血管并发症
慢性肾脏病患者病程记录标准化护理术语的开发。
Front Nutr. 2024 Feb 1;11:1324606. doi: 10.3389/fnut.2024.1324606. eCollection 2024.
4
Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence.维生素K与慢性肾脏病中的血管钙化:当前证据更新
Tzu Chi Med J. 2022 Jul 26;35(1):44-50. doi: 10.4103/tcmj.tcmj_100_22. eCollection 2023 Jan-Mar.
5
Analysis of malnutrition factors for inpatients with chronic kidney disease.慢性肾脏病住院患者营养不良因素分析
Front Nutr. 2023 Jan 6;9:1002498. doi: 10.3389/fnut.2022.1002498. eCollection 2022.
6
VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial.维生素 K 在腹膜透析中的应用(维基百科):一项随机对照试验的原理和研究方案。
PLoS One. 2022 Aug 17;17(8):e0273102. doi: 10.1371/journal.pone.0273102. eCollection 2022.
7
Vitamin K status, all-cause mortality, and cardiovascular disease in adults with chronic kidney disease: the Chronic Renal Insufficiency Cohort.慢性肾脏病成人患者的维生素K状态、全因死亡率和心血管疾病:慢性肾功能不全队列研究
Am J Clin Nutr. 2022 Mar 4;115(3):941-948. doi: 10.1093/ajcn/nqab375.
8
Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort study.肾功能与癌症风险:一项队列研究中使用肌酐和胱抑素C的分析
EClinicalMedicine. 2021 Jul 26;38:101030. doi: 10.1016/j.eclinm.2021.101030. eCollection 2021 Aug.
9
Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein.慢性肾脏病中的血管钙化:维生素K依赖的基质Gla蛋白的作用
Front Med (Lausanne). 2020 Apr 24;7:154. doi: 10.3389/fmed.2020.00154. eCollection 2020.
Curr Opin Nephrol Hypertens. 2016 Nov;25(6):536-544. doi: 10.1097/MNH.0000000000000280.
4
Low vitamin K1 intake in haemodialysis patients.血液透析患者维生素 K1 摄入量低。
Clin Nutr. 2017 Apr;36(2):601-607. doi: 10.1016/j.clnu.2016.04.024. Epub 2016 Apr 28.
5
Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.血浆去磷酸化未羧化基质Gla蛋白作为慢性肾脏病晚期肾损伤和心血管风险的标志物
Kidney Blood Press Res. 2016;41(3):231-9. doi: 10.1159/000443426. Epub 2016 Apr 21.
6
Association Between Vitamin K and the Metabolic Syndrome: A 10-Year Follow-Up Study in Adults.维生素K与代谢综合征之间的关联:一项针对成年人的10年随访研究
J Clin Endocrinol Metab. 2015 Jun;100(6):2472-9. doi: 10.1210/jc.2014-4449. Epub 2015 Apr 2.
7
Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease.终末期肾病患者亚临床维生素K缺乏潜在生物标志物的评估
Can J Kidney Health Dis. 2014 Jun 24;1:13. doi: 10.1186/2054-3581-1-13. eCollection 2014.
8
Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.去磷酸化未羧化基质γ-羧基谷氨酸蛋白浓度可预测维生素K状态,且与一组血液透析患者的血管钙化相关。
BMC Nephrol. 2014 Sep 4;15:145. doi: 10.1186/1471-2369-15-145.
9
Association of Pulmonary Hypertension with Mortality in Incident Peritoneal Dialysis Patients.新发病腹膜透析患者肺动脉高压与死亡率的关联
Perit Dial Int. 2015 Sep-Oct;35(5):537-44. doi: 10.3747/pdi.2013.00332. Epub 2014 Sep 2.
10
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.慢性肾衰竭患者死亡率的流行病学、影响因素和临床试验。
Lancet. 2014 May 24;383(9931):1831-43. doi: 10.1016/S0140-6736(14)60384-6.